PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447028
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447028
Virginiamycin Market Forecasts to 2030 - Global Analysis By Type (Poultry, Aquaculture and Other Types), Animal (Companion Animals, Cattle, Swine and Other Animals), Distribution Channel, Application and by Geography
According to Stratistics MRC, the Global Virginiamycin Market is accounted for $185.05 million in 2023 and is expected to reach $307.01 million by 2030 growing at a CAGR of 7.5% during the forecast period. Virginiamycin is a strong antibiotic that is also used as a feed additive in livestock and poultry farming to boost growth and guard against bacterial infections. Virginiamycin M1 and Virginiamycin S1, its two closely related components, make up this antibiotic that is a member of the streptogramin group. Additionally, these elements suppress bacterial growth by preventing protein synthesis in the cells. Due to its exceptional efficacy against Gram-positive bacteria, Virginiamycin is a valuable tool for disease prevention and enhancing animal health in general.
According to the American Veterinary Medical Association (AVMA), the responsible use of antibiotics, including compounds such as Virginiamycin, is crucial in ensuring the health and well-being of animals in agricultural settings.
Market Dynamics:
Driver:
Increasing production of livestock
The growing demand for livestock products worldwide is one of the major factors driving the Virginiamycin market. To meet the rising demand for meat and dairy products, efficient and sustainable livestock production is becoming more and more important as the world's population continues to rise. Moreover, virginiamycin is a major factor in favor of intensive animal farming practices because it helps to prevent infections and promote growth in livestock.
Restraint:
Antibiotic resistance concerns
The increasing worry about antibiotic resistance is one of the major factors affecting the Virginiamycin market. The widespread and ongoing use of antibiotics, such as Virginiamycin, in cattle may be a factor in the emergence of bacterial strains that are resistant. Furthermore, due to the fact that resistant bacteria may spread to humans via the food chain, this puts public health at risk in addition to that of animals. It also reduces the antibiotics' long-term efficacy.
Opportunity:
Growing use of accurate livestock production
The market for virginiamycin is expected to benefit from the increasing use of precision livestock farming, which is being fueled by developments in automation, data analytics, and sensor technologies. Moreover, virginiamycin and other feed additives can be applied precisely to maximize growth and health outcomes. Precision farming makes it possible to monitor animal health parameters and feed efficiency more precisely.
Threat:
Growing restraints on regulations
The increasing regulatory scrutiny and tightening restrictions on the use of antibiotics in livestock farming pose a serious threat to the Virginiamycin market. Stricter regulations are being put in place by governments and international organizations in response to worries about antibiotic resistance, which may restrict the supply and use of Virginiamycin. Furthermore, market participants face challenges in adhering to changing regulatory standards.
Covid-19 Impact:
Due to supply chain disruptions, labor shortages, and economic uncertainties that have impacted the entire agriculture and livestock industry, the COVID-19 pandemic has had a significant impact on the Virginiamycin market. Lockdowns and restrictions brought on by the pandemic created logistical difficulties that hampered the manufacture and distribution of feed additives, such as Virginiamycin. Moreover, some cattle producers have reevaluated their expenditures as a result of the economic fallout, which could affect the market for these additives.
The Poultry segment is expected to be the largest during the forecast period
In the market for Virginiamycin, poultry farming has the largest share. To encourage growth and guard against bacterial infections in hens and other poultry species, the poultry industry uses Virginiamycin as a feed additive liberally. The need for effective and sustainable poultry farming practices has grown as a result of the world's constant demand for poultry products, which is being driven by population growth and shifting food preferences. Additionally, a useful tool for preserving the wellbeing and output of chicken flocks is Virginiamycin, due to its potency against Gram-positive bacteria.
The Feed Additive for Cattle and Poultry segment is expected to have the highest CAGR during the forecast period
Feed Additive for Cattle and Poultry is the Virginiamycin market segment with the highest CAGR. Due to the rising demand for meat and poultry products as well as the necessity of using sustainable animal production methods, this market is expanding significantly. The antibiotic feed additive virginiamycin is highly prized for its ability to treat and prevent diseases in cattle and poultry, including coccidiosis and necrotic enteritis. Furthermore, it also stimulates growth, increasing feed conversion effectiveness, encouraging weight gain, and improving the general health of the animal.
Region with largest share:
North America is probably the region with the largest share of the Virginiamycin market. Because of its well-established livestock industry and strong demand for meat and poultry products, North America is a major consumer of Virginiamycin. The adoption of Virginiamycin as a feed additive for cattle and poultry is also influenced by the region's strict regulations regarding food safety and animal health. Moreover, the promotion of sustainable animal production methods is another major priority in North America, which supports the expansion of the Virginiamycin market there.
Region with highest CAGR:
The Asia-Pacific region is anticipated to have the highest CAGR in the Virginiamycin market. The demand for Virginiamycin as a feed additive for cattle and poultry is rising significantly in the Asia-Pacific area. The growing population, rising disposable income, and shifting dietary preferences-which result in a greater consumption of meat and poultry products-are the main drivers of this growth. Furthermore, the area is witnessing a transition towards more intensive methods of animal husbandry, thereby requiring the application of antibiotics such as Virginiamycin to prevent infections and enhance growth.
Key players in the market
Some of the key players in Virginiamycin market include Elanco, Merck Animal Health, Ceva, Merial, Bayer Animal Health, Phibro Animal Health Corporation, Vetoquinol, Boehringer Ingelheim, Virbac and Zoetis.
Key Developments:
In November 2023, CEVA Logistics completed its acquisition of Stellar Value Chain. CEVA acquired a 96% stake in the Mumbai-based warehousing and transportation specialists from an affiliate of private equity form Warburg Pincus and other shareholders. The acquisition adds to CEVA's existing presence in India, allowing for the delivery of holistic supply chain services to customers across the Asia Pacific region and beyond.
In August 2023, Merck Animal Health announced Dec. 6 that it has acquired Prondil S.A., a privately held company specializing in the development and manufacturing of animal health vaccines for livestock. Specific terms of the agreement were not disclosed. Prondil, located in Montevideo, Uruguay, is an internationally recognized supplier of antigens and vaccines for veterinary use. The company's wide range of products is sold in more than 20 countries.
In May 2023, Elanco Animal Health Incorporated has entered into an agreement with Aptimmune Biologics, Inc., as the exclusive distributor of their porcine reproductive and respiratory syndrome inactivated, or killed, vaccine based on Aptimmune's Barricade technology platform in the United States. An inactivated vaccine is one consisting of virus particles, bacteria or other pathogens that have been grown in culture and then killed to destroy disease-producing capacity.
Types Covered:
- Poultry
- Aquaculture
- Other Types
Animals Covered:
- Companion Animals
- Cattle
- Swine
- Other Animals
Distribution Channels Covered:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Applications Covered:
- Necrotic enteritis
- Coccidiosis
- Growth Stimulation
- Feed Additive for Cattle and Poultry
- Other Applications
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- sAsia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Virginiamycin Market, By Type
- 5.1 Introduction
- 5.2 Poultry
- 5.3 Aquaculture
- 5.4 Other Types
6 Global Virginiamycin Market, By Animal
- 6.1 Introduction
- 6.2 Companion Animals
- 6.3 Cattle
- 6.4 Swine
- 6.5 Other Animals
7 Global Virginiamycin Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Hospital Pharmacies
- 7.3 Retail Pharmacies
- 7.4 Online Pharmacies
8 Global Virginiamycin Market, By Application
- 8.1 Introduction
- 8.2 Necrotic enteritis
- 8.3 Coccidiosis
- 8.4 Growth Stimulation
- 8.5 Feed Additive for Cattle and Poultry
- 8.6 Other Applications
9 Global Virginiamycin Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Elanco
- 11.2 Merck Animal Health
- 11.3 Ceva
- 11.4 Merial
- 11.5 Bayer Animal Health
- 11.6 Phibro Animal Health Corporation
- 11.7 Vetoquinol
- 11.8 Boehringer Ingelheim
- 11.9 Virbac
- 11.10 Zoetis
List of Tables
- Table 1 Global Virginiamycin Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 3 Global Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 4 Global Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 5 Global Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 6 Global Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 7 Global Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 8 Global Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 9 Global Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 10 Global Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 11 Global Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 12 Global Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 13 Global Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 14 Global Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 15 Global Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 16 Global Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 17 Global Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 18 Global Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 19 Global Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 20 Global Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 21 North America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
- Table 22 North America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 23 North America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 24 North America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 25 North America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 26 North America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 27 North America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 28 North America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 29 North America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 30 North America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 31 North America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 32 North America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 33 North America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 34 North America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 35 North America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 36 North America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 37 North America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 38 North America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 39 North America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 40 North America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 41 Europe Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
- Table 42 Europe Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 43 Europe Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 44 Europe Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 45 Europe Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 46 Europe Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 47 Europe Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 48 Europe Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 49 Europe Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 50 Europe Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 51 Europe Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 52 Europe Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 53 Europe Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 54 Europe Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 55 Europe Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 56 Europe Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 57 Europe Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 58 Europe Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 59 Europe Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 60 Europe Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 61 Asia Pacific Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
- Table 62 Asia Pacific Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 63 Asia Pacific Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 64 Asia Pacific Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 65 Asia Pacific Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 66 Asia Pacific Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 67 Asia Pacific Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 68 Asia Pacific Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 69 Asia Pacific Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 70 Asia Pacific Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 71 Asia Pacific Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 72 Asia Pacific Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 73 Asia Pacific Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 74 Asia Pacific Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 75 Asia Pacific Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 76 Asia Pacific Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 77 Asia Pacific Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 78 Asia Pacific Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 79 Asia Pacific Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 80 Asia Pacific Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 81 South America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
- Table 82 South America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 83 South America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 84 South America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 85 South America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 86 South America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 87 South America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 88 South America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 89 South America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 90 South America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 91 South America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 92 South America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 93 South America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 94 South America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 95 South America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 96 South America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 97 South America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 98 South America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 99 South America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 100 South America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 101 Middle East & Africa Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
- Table 102 Middle East & Africa Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
- Table 103 Middle East & Africa Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
- Table 104 Middle East & Africa Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
- Table 105 Middle East & Africa Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
- Table 106 Middle East & Africa Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
- Table 107 Middle East & Africa Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
- Table 108 Middle East & Africa Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
- Table 109 Middle East & Africa Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
- Table 110 Middle East & Africa Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
- Table 111 Middle East & Africa Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 112 Middle East & Africa Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 113 Middle East & Africa Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 114 Middle East & Africa Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 115 Middle East & Africa Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
- Table 116 Middle East & Africa Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
- Table 117 Middle East & Africa Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
- Table 118 Middle East & Africa Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
- Table 119 Middle East & Africa Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
- Table 120 Middle East & Africa Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
